From RWE Studies to RWD Lakes: Architecting Continuous Evidence
The traditional one-off RWE study model — commission a study, wait 9-18 months, receive a point-in-time report — is no longer fit for purpose for most commercial and late-stage teams. Leading sponsors are shifting toward long-lived Real-World Data lakes that power continuous evidence generation across the entire product lifecycle.
The Shift From Project to Platform
Historically, RWE was commissioned project-by-project: a regulatory team would need a post-market safety study, an HEOR team would need a comparative effectiveness analysis, and a commercial team would need a burden-of-illness report. Each ran as a siloed engagement with separate data pulls, separate IRBs, and separate vendor contracts. Today, forward-thinking sponsors are collapsing those silos into a single governed RWD asset.
Core Pillars of a Clinical-Grade RWD Lake
- OMOP CDM v5.4 / v6 common data model with provenance tracking across all source datasets
- Granular data-access governance: purpose-of-use, protocol, IRB reference, and expiry per column
- Event-driven ingestion pipeline (RabbitMQ) logging every extract, transform, and linkage operation for 21 CFR Part 11 auditability
- Curated phenotype libraries — validated cohort definitions versioned alongside the data
- Federated query layer supporting HIPAA/ GDPR-compliant analysis without moving data across borders
What Continuous Evidence Looks Like in Practice
One of our top-15 pharma sponsors stood up an RWD lake in 2024 for a single Phase 4 oncology submission. Today the same lake powers 14 active use cases across four brands — from routine safety signal monitoring, to comparative effectiveness for payer negotiations, to line-of-therapy trajectory analyses for medical affairs.
Getting Started Without Boiling the Ocean
The good news is you do not need to pre-integrate every available EHR and claims dataset on day one. The highest-ROI RWD lakes start with a single therapeutic area, a single source, and a single concrete use case — then expand deliberately once the first business case has paid for itself.